Format

Send to

Choose Destination
Biomark Med. 2013 Feb;7(1):93-8. doi: 10.2217/bmm.12.95.

MMP-9 (-1562 C:T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia.

Author information

1
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. zrahimi@kums.ac.ir

Abstract

AIM:

To investigate the role of MMP-9 (-1562 C:T) polymorphism as a biomarker for susceptibility to pre-eclampsia.

PATIENTS & METHODS:

MMP-9 variants were detected in 160 women with mild and severe pre-eclampsia and 112 healthy pregnant women.

RESULTS:

A significantly higher frequency of MMP-9 CT genotype was observed in both mild and severe pre-eclamptic women compared with controls. In the presence of CT + TT genotype the risk of severe pre-eclampsia increased 2.37-fold (p = 0.02). In women with early-onset pre-eclampsia the frequency of MMP-9 CT + TT genotype was significantly higher (p = 0.045) compared with those with late-onset pre-eclampsia.

CONCLUSION:

The MMP-9 variant could be a useful biomarker of susceptibility to severe pre-eclampsia and early-onset severe pre-eclampsia.

PMID:
23387490
DOI:
10.2217/bmm.12.95
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center